Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common / Ordinary Stock
-
Total 13F shares
-
4,693,568
-
Share change
-
-157,511
-
Total reported value
-
$198,727,915
-
Put/Call ratio
-
90%
-
Price per share
-
$42.34
-
Number of holders
-
91
-
Value change
-
-$6,621,701
-
Number of buys
-
46
-
Number of sells
-
42
Institutional Holders of Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) as of Q1 2024
As of 31 Mar 2024,
Taro Pharmaceutical Industries Ltd - Common / Ordinary Stock (TARO) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,693,568 shares.
The largest 10 holders included
Krensavage Asset Management, LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, BRANDES INVESTMENT PARTNERS, LP, Eversept Partners, LP, Qube Research & Technologies Ltd, AMERIPRISE FINANCIAL INC, STATE STREET CORP, and HSBC HOLDINGS PLC.
This page lists
91
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.